Literature DB >> 23786112

[Update on current care guidelines: asthma].

Tari Haahtela1, Lauri Lehtimäki, Eeva Ahonen, Terttu Harju, Tuomas Jartti, Hannu Kankaanranta, Krista Korhonen, Mika Mäkelä, Marja Puurunen, Anssi Sovijärvi, Erkka Valovirta, Kari K K Venho.   

Abstract

Asthma is an inflammatory disease of the lower airways. The typical symptoms of asthma are cough, wheezing and shortness of breath. Asthma is diagnosed based on measures of pulmonary function showing variable or reversible airways obstruction. The basic pharmacological treatment consists of alleviating the asthmatic inflammation with regular inhaled glucocorticoids and relieving sudden obstructions with as-needed inhaled beta2-agonists. The treatment is adjusted based on asthma control. If good control of asthma is not achieved with low to medium doses of inhaled glucocorticoids, additional control medication (inhaled long acting beta2-agonists, antileukotrienes, in adults also theophylline or tiotrohium) should be introduced.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23786112

Source DB:  PubMed          Journal:  Duodecim        ISSN: 0012-7183


  9 in total

1.  Documentation of smoking in scheduled asthma contacts in primary health care: a 12-year follow-up study.

Authors:  Jaana Takala; Iida Vähätalo; Leena E Tuomisto; Onni Niemelä; Pinja Ilmarinen; Hannu Kankaanranta
Journal:  NPJ Prim Care Respir Med       Date:  2022-10-21       Impact factor: 3.289

2.  Seinäjoki Adult Asthma Study (SAAS): a protocol for a 12-year real-life follow-up study of new-onset asthma diagnosed at adult age and treated in primary and specialised care.

Authors:  Hannu Kankaanranta; Pinja Ilmarinen; Terhi Kankaanranta; Leena E Tuomisto
Journal:  NPJ Prim Care Respir Med       Date:  2015-06-25       Impact factor: 2.871

Review 3.  Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.

Authors:  Hannu Kankaanranta; Terttu Harju; Maritta Kilpeläinen; Witold Mazur; Juho T Lehto; Milla Katajisto; Timo Peisa; Tuula Meinander; Lauri Lehtimäki
Journal:  Basic Clin Pharmacol Toxicol       Date:  2015-01-22       Impact factor: 4.080

4.  Observational cross-sectional study on Symptoms Associated to Moisture DAmage at Workplace: the SAMDAW study protocol.

Authors:  Pia Nynäs; Sarkku Vilpas; Elina Kankare; Jussi Karjalainen; Lauri Lehtimäki; Jura Numminen; Antti Tikkakoski; Leenamaija Kleemola; Jukka Uitti
Journal:  BMJ Open       Date:  2019-06-25       Impact factor: 2.692

Review 5.  Bringing asthma care into the twenty-first century.

Authors:  Kjell Larsson; Hannu Kankaanranta; Christer Janson; Lauri Lehtimäki; Björn Ställberg; Anders Løkke; Kristian Høines; Klaus Roslind; Charlotte Suppli Ulrik
Journal:  NPJ Prim Care Respir Med       Date:  2020-06-05       Impact factor: 2.871

6.  Asthma Case Cluster during Renovation of a Water-Damaged and Toxic Building.

Authors:  Saija Hyvönen; Hannu Syrjala
Journal:  Microorganisms       Date:  2019-12-03

7.  Participation in scheduled asthma follow-up contacts and adherence to treatment during 12-year follow-up in patients with adult-onset asthma.

Authors:  Pinja Ilmarinen; Hannu Kankaanranta; Jaana Takala; Iida Vähätalo; Leena E Tuomisto; Onni Niemelä
Journal:  BMC Pulm Med       Date:  2022-02-15       Impact factor: 3.317

8.  Parental smoking and cessation during pregnancy and the risk of childhood asthma.

Authors:  Maijakaisa Harju; Leea Keski-Nisula; Leena Georgiadis; Seppo Heinonen
Journal:  BMC Public Health       Date:  2016-05-24       Impact factor: 3.295

9.  Reduced expiratory variability index (EVI) is associated with controller medication withdrawal and symptoms in wheezy children aged 1-5 years.

Authors:  Ville-Pekka Seppä; Marita Paassilta; Juho Kivistö; Anton Hult; Jari Viik; Javier Gracia-Tabuenca; Jussi Karjalainen
Journal:  Pediatr Allergy Immunol       Date:  2020-03-17       Impact factor: 6.377

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.